Switch theme
Sign up to access all valuation multiples
Jeol Ltd develops and manufactures scientific and metrology instruments, industrial equipment, and medical equipment. The scientific and metrology instruments segment contributes the majority of revenue. It sells electron optics instruments, analytical instruments, and measuring instruments, including electron microscopes, magnetic resonance systems, and mass spectrometers. The industrial equipment segment produces semiconductor equipment and industrial equipment. The medical equipment segment sells clinical chemistry analyzers, rack handlers, laboratory information systems, and amino acid analyzers. Jeol generates the largest proportion of its revenue in Japan, with the second- largest proportion of revenue generated in the United States.
1949
3.0K+
LTM Revenue $1.3B
LTM EBITDA $270M
$1.2B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Jeol has a last 12-month revenue (LTM) of $1.3B and a last 12-month EBITDA of $270M.
In the most recent fiscal year, Jeol achieved revenue of $1.2B and an EBITDA of $235M.
Jeol expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Jeol valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.3B | XXX | $1.2B | XXX | XXX | XXX |
| Gross Profit | $1.3B | XXX | $544M | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | 45% | XXX | XXX | XXX |
| EBITDA | $270M | XXX | $235M | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | 20% | XXX | XXX | XXX |
| EBIT | $237M | XXX | $189M | XXX | XXX | XXX |
| EBIT Margin | 18% | XXX | 16% | XXX | XXX | XXX |
| Net Profit | $130M | XXX | $149M | XXX | XXX | XXX |
| Net Margin | 10% | XXX | 12% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Jeol's stock price is JPY 4048 (or $28).
Jeol has current market cap of JPY 207B (or $1.4B), and EV of JPY 180B (or $1.2B).
See Jeol trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.2B | $1.4B | XXX | XXX | XXX | XXX | $2.55 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Jeol has market cap of $1.4B and EV of $1.2B.
Jeol's trades at 1.1x EV/Revenue multiple, and 5.5x EV/EBITDA.
Equity research analysts estimate Jeol's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Jeol has a P/E ratio of 10.9x.
See valuation multiples for Jeol and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.4B | XXX | $1.4B | XXX | XXX | XXX |
| EV (current) | $1.2B | XXX | $1.2B | XXX | XXX | XXX |
| EV/Revenue | 0.9x | XXX | 1.1x | XXX | XXX | XXX |
| EV/EBITDA | 4.6x | XXX | 5.5x | XXX | XXX | XXX |
| EV/EBIT | 5.2x | XXX | 6.8x | XXX | XXX | XXX |
| EV/Gross Profit | 0.9x | XXX | n/a | XXX | XXX | XXX |
| P/E | 10.9x | XXX | 10.0x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 22.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialJeol's last 12 month revenue growth is -2%
Jeol's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.
Jeol's rule of 40 is 17% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Jeol's rule of X is 15% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Jeol and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | -2% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | 19% | XXX | XXX | XXX |
| EBITDA Growth | -14% | XXX | 8% | XXX | XXX | XXX |
| Rule of 40 | 17% | XXX | 17% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 15% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 6% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 30% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Catapult | XXX | XXX | XXX | XXX | XXX | XXX |
| Optiscan Imaging | XXX | XXX | XXX | XXX | XXX | XXX |
| NanoFocus | XXX | XXX | XXX | XXX | XXX | XXX |
| Q-Interline | XXX | XXX | XXX | XXX | XXX | XXX |
| Jenoptik | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Jeol acquired XXX companies to date.
Last acquisition by Jeol was XXXXXXXX, XXXXX XXXXX XXXXXX . Jeol acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Jeol founded? | Jeol was founded in 1949. |
| Where is Jeol headquartered? | Jeol is headquartered in Japan. |
| How many employees does Jeol have? | As of today, Jeol has 3.0K+ employees. |
| Who is the CEO of Jeol? | Jeol's CEO is Mr. Izumi Oi. |
| Is Jeol publicy listed? | Yes, Jeol is a public company listed on TKS. |
| What is the stock symbol of Jeol? | Jeol trades under 6951 ticker. |
| When did Jeol go public? | Jeol went public in 1962. |
| Who are competitors of Jeol? | Similar companies to Jeol include e.g. Catapult, Optiscan Imaging, NanoFocus, Q-Interline. |
| What is the current market cap of Jeol? | Jeol's current market cap is $1.4B |
| What is the current revenue of Jeol? | Jeol's last 12 months revenue is $1.3B. |
| What is the current revenue growth of Jeol? | Jeol revenue growth (NTM/LTM) is -2%. |
| What is the current EV/Revenue multiple of Jeol? | Current revenue multiple of Jeol is 0.9x. |
| Is Jeol profitable? | Yes, Jeol is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Jeol? | Jeol's last 12 months EBITDA is $270M. |
| What is Jeol's EBITDA margin? | Jeol's last 12 months EBITDA margin is 20%. |
| What is the current EV/EBITDA multiple of Jeol? | Current EBITDA multiple of Jeol is 4.6x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
